Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
AstraZeneca to present data demonstrating diversity of its portfolio of innovative formulations and devices at the European Respiratory Society International Congress 2015
-
AstraZeneca supports crowd sourcing challenge to find new combination therapies for cancer
-
AstraZeneca presents positive pooled analysis demonstrating the effect of dapagliflozin on albuminuria in hypertensive patients with type 2 diabetes
-
AstraZeneca announces new tolerability, long-term efficacy and real-world adherence data for exenatide once weekly in patients with type 2 diabetes
-
AstraZeneca to present comprehensive data from its diabetes portfolio and pre-clinical research at EASD 2015
-
AstraZeneca purchases US biologics manufacturing facility to support growing pipeline
-
AstraZeneca to invest £11.5 million in new clinical oncology bioinformatics collaboration with The University of Manchester
-
AstraZeneca to update on leading lung cancer portfolio at WCLC 2015
-
US FDA approves expanded indication for BRILINTA to include long-term use in patients with a history of heart attack
-
AstraZeneca enters license agreement with Daiichi Sankyo for development and commercialisation of FluMist in Japan
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here